Predictors of Length of Hospital Stay After Complete Repair for Tetralogy of Fallot: A Prospective Cohort Study
Overview
Authors
Affiliations
Background: We sought to identify patient and surgical factors associated with time to hospital discharge in patients undergoing complete repair for tetralogy of Fallot.
Methods And Results: We performed a prospective cohort study of patients with tetralogy of Fallot admitted for complete repair between May 1, 2012 and June 2, 2017 at Children's Hospital of Philadelphia with detailed demographic, clinical, and operative characteristics. The primary outcome was time to hospital discharge. Cox proportional hazards models were used to identify patient and operative predictors of time to hospital discharge. We enrolled 151 subjects, 62.8% male, 65.6% non-Hispanic white, and 9.9% non-Hispanic black. The median time to hospital discharge was 7 days (interquartile range 4, 12). Five patients died in the hospital, all of whom underwent tetralogy of Fallot repair beyond the neonatal period. Greater birth weight was associated with higher rate of hospital discharge (hazard ratio [HR]=1.35, 95% confidence interval (CI) =1.11, 1.64), while absent pulmonary valve versus pulmonary stenosis (HR=0.27, 95% CI=0.08, 0.91), pulmonary valve atresia versus pulmonary stenosis (HR=0.57, 95% CI=0.33, 0.97), presence of aortopulmonary collaterals (HR=0.44, 95% CI=0.24, 0.84), complete repair performed in the neonatal period (<30 days of life) (HR=0.45, 95% CI=0.27, 0.75), more than 1 cardiopulmonary bypass run (HR=0.33, 95% CI=0.18, 0.61), and longer aortic cross-clamp time (HR [per 10 minutes]=0.88, 95% CI=0.79, 0.97) were associated with lower rate of hospital discharge.
Conclusions: Postoperative hospital stay after complete repair of tetralogy of Fallot is in part determined by patient and operative factors. Some (eg, surgical strategy for the symptomatic neonate) may be modifiable. These results may impact patient counseling, choice of surgical approach, and postoperative care.
Schaffner D, Maitre G, Lava S, Boegli Y, Dolci M, Pfister R Int J Cardiol Congenit Heart Dis. 2024; 10:100414.
PMID: 39713600 PMC: 11658541. DOI: 10.1016/j.ijcchd.2022.100414.
Al Ghafri M, Al Toubi S, Maddali M, Sathiya P, Jose S, Al-Kindi H Sultan Qaboos Univ Med J. 2024; 24(4):540-547.
PMID: 39634813 PMC: 11614016. DOI: 10.18295/squmj.11.2024.077.
Hussain A, Younes M BMC Pediatr. 2024; 24(1):499.
PMID: 39097678 PMC: 11297559. DOI: 10.1186/s12887-024-04976-9.
Neurodevelopment in patients with repaired tetralogy of Fallot.
Mercer-Rosa L, Favilla E Front Pediatr. 2024; 12:1137131.
PMID: 38737635 PMC: 11082288. DOI: 10.3389/fped.2024.1137131.
Clinically Relevant Genetic Considerations for Patients With Tetralogy of Fallot.
Bassett A, Reuter M, Malecki S, Silversides C, Oechslin E CJC Pediatr Congenit Heart Dis. 2024; 2(6Part A):426-439.
PMID: 38161665 PMC: 10755827. DOI: 10.1016/j.cjcpc.2023.10.002.